Medication Guide. PAROXETINE (pa rox e teen) EXTENDED-RELEASE TABLETS, USP. Rx Only

Similar documents
Reference ID:

Medication Guide. Escitalopram (ES-sye-TAL-oh-pram) Tablets USP

Medication Guide SARAFEM (SAIR-a-fem) (fluoxetine hydrochloride) Tablets

1.Suicidal thoughts or actions:

Medication Guide Escitalopram Tablets (ES-sye-TAL-oh-pram)

Medication Guide. Sertraline Hydrochloride (ser' tra leen hye'' droe klor' ide) Tablets

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

Citalopram tablets and other antidepressant medicines may cause serious side effects, including:

Medication Guide Fluoxetine Oral Solution USP What is the most important information I should know about fluoxetine oral solution?

Medication Guide Sertraline Hydrochloride Tablets (ser-tra-leen HYE-droe-KLOR-ide)

(levomilnacipran) extended-release capsules

MEDICATION GUIDE SERTRALINE HYDROCHLORIDE TABLETS, USP

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets

Medication Guide. Sertraline Hydrochloride Tablets USP. (ser tra leen)

3. Severe allergic reactions: trouble breathing swelling of the face, tongue, eyes or mouth

What else do I need to know about antidepressant medicines?

Medication Guide Fluoxetine Tablets, USP

Medication Guide. Cymbalta. (duloxetine delayed-release capsules)

Medication Guide REMERONSolTab (rĕm' - ĕ - rŏn - sŏl' tăb) (mirtazapine) Orally Disintegrating Tablets

Doctor Discussion Guide

Medication Guide Duloxetine Delayed-Release Capsules USP (doo lox' e teen)

MEDICATION GUIDE. desvenlafaxine extended-release tablets (des VEN la FAX een)

Keep all follow-up visits with your healthcare provider and call between visits if you are worried about symptoms.

17.11 FDA-Approved Medication Guide Medication Guide LUVOX CR (LOO Vox CR) (Fluvoxamine Maleate) Extended-Release Capsules

MEDICATION GUIDE FLUOXETINE CAPSULES USP

MEDICATION GUIDE Fluvoxamine Tablets (Flu VOX ah meen) What is the most important information I should know about fluvoxamine maleate tablets?

MEDICATION GUIDE FLUOXETINE TABLETS. What is the most important information I should know about fluoxetine?

17.8 Alcohol As with other psychotropic medications, patients should be advised to avoid alcohol while taking LUVOX CR Capsules.

MEDICATION GUIDE. Quetiapine (kwe-tye-a-peen) Tablets USP

MEDICATION GUIDE LEVETIRACETAM (LEE-ve-tye-RA-se-tam) TABLETS USP 250 mg, 500 mg, 750 mg and 1000 mg Rx only

What else do I need to know about antidepressant medicines?

MEDICATION GUIDE BuPROPion Hydrochloride Extended-Release Tablets, USP (SR) (byoo-proe-pee-on)

Medication Guide. What is the most important information I should know about SYMBYAX? SYMBYAX may cause serious side effects, including:

MEDICATION GUIDE Olanzapine and Fluoxetine Capsules, USP (oh-lan-zah-peen and floo-ox-eh-teen)

Noven Enters Co-Promotion Agreement with Shionogi for Brisdelle (Paroxetine) Capsules MIAMI and NEW YORK, January 13, 2014

Zydus Pharmaceuticals USA Inc. MEDICATION GUIDE

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

The presentations at NAMS reference Brisdelle as LDMP (low-dose mesylate salt of paroxetine), as it was referred to in clinical development.

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S.

DIVALPROEX (di val pro ex) SODIUM DELAYED-RELEASE TABLETS, USP

What is the most important information I should know about carbamazepine tablets or chewable tablets?

MEDICATION GUIDE Quetiapine Fumarate Extended-Release Tablets (Kwe-TYE-a-peen FUE-ma-rate)

MEDICATION GUIDE TOPIRAMATE

MEDICATION GUIDE Levetiracetam (LEE-ve-tye-RA-se-tam) Extended-Release Tablets, USP Rx Only

MEDICATION GUIDE LAMOTRIGINE TABLETS

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules

MEDICATION GUIDE. Aripiprazole Tablets (AR-i-PIP-ra-zole)

attempts to commit suicide acting aggressive, being angry, or violent

Reference ID:

MEDICATION GUIDE LAMICTAL

(topiramate) Tablets and Sprinkle Capsules

Medication Guide Clonazepam Tablets USP (kloe-na-za-pam)

What is the most important information I should know about levetiracetam tablets?

FDA APPROVED MEDICATION GUIDE

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

Reference ID:

take a higher starting dose of LAMICTAL than your healthcare provider prescribed increase your dose of LAMICTAL faster than prescribed.

Specific Populations (8.1)].

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP)

MEDICATION GUIDE ONFI (ON-fee) (clobazam) Tablets and Oral Suspension

MEDICATION GUIDE Quetiapine Fumarate Tablets

a build up of acid in your blood due to ketones (ketoacidosis) coma death

MEDICATION GUIDE WELLBUTRIN SR (WELL byu-trin) (bupropion hydrochloride) Sustained-Release Tablets

Patient Information. Telmisartan and Hydrochlorothiazide (TEL-mi-SAR-tan and HYE-droe-KLOR-oh-THYE-a-zide) Tablets. Rx Only

Your B.E.D. Discussion Guide

The Importance of Taking AUSTEDO (deutetrabenazine) Tablets as Prescribed

A Helpful Guide When Starting

MEDICATION GUIDE. Reference ID:

Doctor Discussion Guide

FDA-approved Medication Guide MEDICATION GUIDE. RIBASPHERE (Rīb-ă-sphere) Tablets

Doctor Discussion Guide

STRATTERA (Stra-TAIR-a)

MEDICATION GUIDE. Rabeprazole Sodium Delayed-Release Tablets Rx Only

17.9 Food Patients may take STRATTERA with or without food.

PATIENT INFORMATION. Metformin Hydrochloride Extended-Release Tablets USP (met-for-min HYE-droe-KLOR-ide)

PATIENT INFORMATION Metformin Hydrochloride Extended-Release Tablets (met-for-min HYE-droe-KLOR-ide) Rx only

MEDICATION GUIDE Abacavir, Lamivudine and Zidovudine Tablets (a-bak-a-vir, la-miv-ue-deen, zye-doe-vue-deen)

Patient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets

IMPORTANT: PLEASE READ

MEDICATION GUIDE JANTOVEN (JAN-to-ven) Tablets (Warfarin Sodium Tablets, USP)

TETRAZIN (tetrabenazine) Tablets MEDICATION GUIDE. What is the most important information I should know about TETRAZIN?

MEDICATION GUIDE Prasugrel (pra-su-grel) tablets Read this Medication Guide before you start taking prasugrel and each time you get a refill.

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)

MEDICATION GUIDE PRADAXA (pra dax a) (dabigatran etexilate mesylate) capsules

Share the important information in this Medication Guide with members of your household.

Patient Information MICARDIS HCT (my-car-dis HCT) (telmisartan and hydrochlorothiazide) Tablets

Medication Guide Plavix (PLAV-iks) (clopidogrel bisulfate) tablets

Patient Information. For patients with diabetes, if you are taking TWYNSTA you should not take aliskiren.

STRATTERA Generic name: atomoxetine hydrochloride

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

Patient Information Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg, 100 mg/12.5 mg and 100 mg/25 mg Rx only

MEDICATION GUIDE XIGDUO XR (ZIG- DO- OH X- R) (dapagliflozin and metformin HCL extended-release) Tablets

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

IMPORTANT: PLEASE READ

Oseltamivir phosphate capsule does not treat or prevent illness that is caused by infections other than the influenza virus.

SERTRALINE Page 52 of 56 IMPORTANT: PLEASE READ

Transcription:

Medication Guide PAROXETINE (pa rox e teen) EXTENDED-RELEASE TABLETS, USP Rx Only Paroxetine extended-release tablets, 12.5 mg contain FD&C Yellow No. 5 (tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity. Read the Medication Guide that comes with paroxetine extended-release tablets before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your healthcare provider about your medical condition or treatment. Talk with your healthcare provider if there is something you do not understand or want to learn more about. What is the most important information I should know about paroxetine extended-release tablets? Paroxetine extended-release tablets and other antidepressant medicines may cause serious side effects, including: 1. Suicidal thoughts or actions: Paroxetine extended-release tablets and other antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults within the first few months of treatment or when the dose is changed. Depression or other serious mental illnesses are the most important causes of suicidal thoughts and actions. Watch for these changes, and call your healthcare provider right away if you notice: New or sudden changes, in mood, behavior, actions, thoughts, or feelings, especially if severe. Pay particular attention to such changes when paroxetine extended-release tablets is started or when the dose is changed. Keep all follow-up visits with your healthcare provider and call between visits if you are worried about symptoms. Call your healthcare provider right away if you have any of the following symptoms, or call 911 if an emergency, especially if they are new, worse, or worry you: attempts to commit suicide acting on dangerous impulses acting aggressive or violent thoughts about suicide or dying new or worse depression new or worse anxiety or panic attacks feeling agitated, restless, angry, or irritable trouble sleeping an increase in activity and talking more than what is normal for you other unusual changes in behavior or mood Page 1 of 7

Call your healthcare provider right away if you have any of the following symptoms, or call 911 if an emergency. Paroxetine extended-release tablets may be associated with these serious side effects: 2. Serotonin Syndrome or Neuroleptic Malignant Syndrome-like reactions. This condition can be life-threatening and may include: agitation, hallucinations, coma, or other changes in mental status coordination problems or muscle twitching (overactive reflexes) racing heartbeat, high or low blood pressure sweating or fever nausea, vomiting, or diarrhea muscle rigidity 3. Visual problems eye pain changes in vision swelling or redness in or around the eye Only some people are at risk for these problems. You may want to undergo an eye examination to see if you are at risk and receive preventative treatment if you are. 4. Severe allergic reactions: trouble breathing swelling of the face, tongue, eyes, or mouth rash, itchy welts (hives), or blisters, alone or with fever or joint pain 5. Abnormal bleeding: Paroxetine extended-release tablets and other antidepressant medicines may increase your risk of bleeding or bruising, especially if you take the blood thinner warfarin (Coumadin, Jantoven ), a non-steroidal anti-inflammatory drug (NSAIDs, like ibuprofen or naproxen), or aspirin. 6. Seizures or convulsions 7. Manic episodes: greatly increased energy severe trouble sleeping racing thoughts reckless behavior unusually grand ideas excessive happiness or irritability talking more or faster than usual 8. Changes in appetite or weight. Children and adolescents should have height and weight monitored during treatment. 9. Low salt (sodium) levels in the blood. Elderly people may be at greater risk for this. Symptoms may include: headache weakness or feeling unsteady confusion, problems concentrating or thinking, or memory problems Do not stop paroxetine extended-release tablets without first talking to your healthcare provider. Stopping paroxetine extended-release tablets too quickly may cause serious symptoms including: Page 2 of 7

anxiety, irritability, high or low mood, feeling restless, or changes in sleep habits headache, sweating, nausea, dizziness electric shock-like sensations, shaking, confusion What are paroxetine extended-release tablets? Paroxetine extended-release tablets are a prescription medicine used to treat depression. It is important to talk with your healthcare provider about the risks of treating depression and also the risks of not treating it. You should discuss all treatment choices with your healthcare provider. Paroxetine extended-release tablets are also used to treat: Major Depressive Disorder (MDD) Panic Disorder Social Anxiety Disorder Premenstrual Dysphoric Disorder (PMDD) Talk to your healthcare provider if you do not think that your condition is getting better with treatment using paroxetine extended-release tablets. Who should not take paroxetine extended-release tablets? Do not take paroxetine extended-release tablets if you: are allergic to paroxetine or any of the ingredients in paroxetine extended-release tablets. See the end of this Medication Guide for a complete list of ingredients in paroxetine extended-release tablets. take a monoamine oxidase inhibitor (MAOI). Ask your healthcare provider or pharmacist if you are not sure if you take an MAOI, including the antibiotic linezolid. Do not take an MAOI within 2 weeks of stopping paroxetine extended-release tablets unless directed to do so by your physician. Do not start paroxetine extended-release tablets if you stopped taking an MAOI in the last 2 weeks unless directed to do so by your physician. People who take paroxetine extended-release tablets close in time to an MAOI may have serious or even life- threatening side effects. Get medical help right away if you have any of these symptoms: high fever uncontrolled muscle spasms stiff muscles rapid changes in heart rate or blood pressure confusion loss of consciousness (pass out) take MELLARIL (thioridazine). Do not take MELLARIL together with paroxetine extended-release tablets because this can cause serious heart rhythm problems or sudden death. take the antipsychotic medicine pimozide (ORAP ) because this can cause serious heart problems. What should I tell my healthcare provider before taking paroxetine extended-release tablets? Ask if you are not sure. Before starting paroxetine extended-release tablets, tell your healthcare provider if you: Page 3 of 7

are pregnant, may be pregnant, or plan to become pregnant. There is a possibility that paroxetine may harm your unborn baby, including an increased risk of birth defects, particularly heart defects. Other risks may include a serious condition in which there is not enough oxygen in the baby s blood. Your baby may also have certain other symptoms shortly after birth. Premature births have also been reported in some women who used paroxetine extended-release tablets during pregnancy. are breastfeeding. Paroxetine hydrochloride passes into your milk. Talk to your healthcare provider about the best way to feed your baby while taking paroxetine extendedrelease tablets. are taking certain drugs such as: triptans used to treat migraine headache other antidepressants (SSRIs, SNRIs, tricyclics, or lithium) or antipsychotics drugs that affect serotonin, such as lithium, tramadol, tryptophan, St. John s wort certain drugs used to treat irregular heart beats certain drugs used to treat schizophrenia certain drugs used to treat HIV infection certain drugs that affect the blood, such as warfarin, aspirin, and ibuprofen certain drugs used to treat epilepsy atomoxetine cimetidine fentanyl metoprolol pimozide procyclidine tamoxifen have liver problems have kidney problems have heart problems have or had seizures or convulsions have bipolar disorder or mania have low sodium levels in your blood have a history of a stroke have high blood pressure have or had bleeding problems have glaucoma (high pressure in the eye) Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Paroxetine extended-release tablets and some medicines may interact with each other, may not work as well, or may cause serious side effects. Your healthcare provider or pharmacist can tell you if it is safe to take paroxetine extendedrelease tablets with your other medicines. Do not start or stop any medicine while taking paroxetine extended-release tablets without talking to your healthcare provider first. Page 4 of 7

If you take paroxetine extended-release tablets, you should not take any other medicines that contain paroxetine, including paroxetine tablets and PEXEVA (paroxetine mesylate). How should I take paroxetine extended-release tablets? Take paroxetine extended-release tablets exactly as prescribed. Your healthcare provider may need to change the dose of paroxetine extended-release tablets until it is the right dose for you. Paroxetine extended-release tablets may be taken with or without food. Paroxetine extended-release tablets should not be chewed or crushed and should be swallowed whole. If you miss a dose of paroxetine extended-release tablets, take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses of paroxetine extended-release tablets at the same time. If you take too much paroxetine extended-release tablets, call your healthcare provider or poison control center right away, or get emergency treatment. Do not stop taking paroxetine extended-release tablets suddenly without talking to your doctor (unless you have symptoms of a severe allergic reaction). If you need to stop taking paroxetine extended-release tablets, your healthcare provider can tell you how to safely stop taking it. What should I avoid while taking paroxetine extended-release tablets? Paroxetine extended-release tablets can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. You should not drive, operate heavy machinery, or do other dangerous activities until you know how paroxetine extended-release tablets affects you. Do not drink alcohol while using paroxetine extended-release tablets. What are possible side effects of paroxetine extended-release tablets? Paroxetine extended-release tablets may cause serious side effects, including all of those described in the section entitled What is the most important information I should know about paroxetine extended-release tablets? Common possible side effects in people who take paroxetine extended-release tablets include: nausea sleepiness feeling anxious or trouble sleeping sexual problems sweating shaking constipation yawning blurred vision diarrhea dry mouth decreased appetite Page 5 of 7

weakness Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of paroxetine extended-release tablets. For more information, ask your healthcare provider or pharmacist. CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 or 1-800-332-1088. How should I store paroxetine extended-release tablets? Store at 25 C (77 F); excursions permitted to 15 to 30 C (59 to 86 F) [see USP Controlled Room Temperature]. Keep paroxetine extended-release tablets away from light. Keep bottle of paroxetine extended-release tablets closed tightly. Keep paroxetine extended-release tablets and all medicines out of the reach of children. General information about paroxetine extended-release tablets Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use paroxetine extended-release tablets for a condition for which it was not prescribed. Do not give paroxetine extended-release tablets to other people, even if they have the same condition. It may harm them. This Medication Guide summarizes the most important information about paroxetine extendedrelease tablets. If you would like more information, talk with your healthcare provider. You may ask your healthcare provider or pharmacist for information about paroxetine extended-release tablets that is written for healthcare professionals. For more information about paroxetine extended-release tablets go to www.lupinpharmaceuticals.com or call Lupin Pharmaceuticals, Inc. at 1-800-399-2561 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch What are the ingredients in paroxetine extended-release tablets? Active ingredient: paroxetine hydrochloride hemihydrate USP Inactive ingredients in tablets: aluminum oxide, colloidal silicon dioxide, hydrogenated vegetable oil, hypromelloses, iron oxide black, lactose monohydrate, magnesium stearate, methacrylic acid co-polymer dispersion, microcrystalline cellulose, polyethylene glycols, povidone, propylene glycol, shellac glaze, talc, titanium dioxide, triacetin and triethyl citrate. The 12.5 mg tablets also contain D&C Yellow No. 10 Aluminum Lake, FD&C Yellow No. 5 Aluminum Lake (tartrazine) and FD&C Yellow No. 6 Aluminum Lake. The 25 mg tablets also contain D&C Red No. 30 Aluminum Lake and FD&C Blue No. 2 Aluminum Lake. The 37.5 mg tablets also contain FD&C Blue No. 1 Aluminum Lake. Page 6 of 7

This Medication Guide has been approved by the U.S. Food and Drug Administration. The brands listed are trademarks of their respective owners and are not trademarks of Lupin Pharmaceuticals, Inc. The makers of these brands are not affiliated with and do not endorse Lupin Pharmaceuticals, Inc. or its products. Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States Manufactured by: Lupin Limited Pithampur (M.P.) - 454 775 India January 2017 ID#: 250687 Page 7 of 7